Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05934136 · ClinicalTrials.gov registry record · NA

Brain Health Program for Older Adults With Subjective Cognitive Decline

A NA study, sponsored by Massachusetts General Hospital.

Completed
Registry status
NA
Development phase
60
Enrollment target

NCT05934136: Completed NA study, sponsored by Massachusetts General Hospital.

NCT05934136 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 60 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT05934136, a NA study, has completed, sponsored by Massachusetts General Hospital.

COMPLETED
Registry status
NA
Development phase
60 participants
Enrollment target

Study Summary

The investigators will compare two brain health programs in older adults with subjective cognitive decline and lifestyle risk factors for dementia. The primary aim of the study is to determine the credibility, expectancy, feasibility, acceptability, appropriateness, fidelity, and satisfaction of the programs.

Primary Outcome

Assesses how believable, convincing, and logical patients perceive the treatment to be. Higher scores (min = 3, max = 27) scores indicate greater credibility and expectancy.

Interventions

  • BEHAVIORAL My Healthy Brain 1
  • BEHAVIORAL My Healthy Brain 2

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2024-01-16
Est. Completion 2025-11-07
Phase NA
Massachusetts General Hospital

2,032 total trials

What the finished NCT05934136 record still lists

NCT05934136 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).

The record links to 0 conditions, and to 2 interventions - of which My Healthy Brain 1 is the first listed.

NCT05934136 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05934136 about?

NCT05934136 is a clinical study titled "Brain Health Program for Older Adults With Subjective Cognitive Decline". The investigators will compare two brain health programs in older adults with subjective cognitive decline and lifestyle risk factors for dementia. The primary aim of the study is to determine the credibility, expectancy, feasibility, acceptability, appropriateness, fidelity, and satisfaction of the...

What is the current status of trial NCT05934136?

This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2024-01-16. Estimated completion is 2025-11-07.

What interventions are being tested in trial NCT05934136?

The interventions under investigation include: My Healthy Brain 1 (BEHAVIORAL), My Healthy Brain 2 (BEHAVIORAL).

Who is sponsoring clinical trial NCT05934136?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT05934136's enrollment target sits among peer trials

60 1164th of 2000 higher than 745 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00576069 · 60 participants

    Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma

  • NCT01297400 · 60 participants · Phase 2

    Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns

  • NCT01734122 · 60 participants

    Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor

  • NCT01804634 · 60 participants · Phase 2

    Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05934136, the US trial registry maintained by the National Library of Medicine. NCT05934136 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.